Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pro Medicus Limited ( (AU:PME) ) has provided an announcement.
Pro Medicus Limited has announced a daily update on its ongoing on-market buy-back program, with a total of 3,915 ordinary fully paid securities bought back on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure effectively, potentially enhancing shareholder value and signaling confidence in its financial health.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$320.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, focusing on providing advanced imaging software and services. The company is known for its innovative solutions that cater to the needs of medical professionals and healthcare facilities, enhancing diagnostic capabilities and operational efficiency.
YTD Price Performance: -0.32%
Average Trading Volume: 173,502
Technical Sentiment Signal: Buy
Current Market Cap: A$26.01B
See more insights into PME stock on TipRanks’ Stock Analysis page.